Bar Shalev Amos Insider Trades

Insider Trading History

Track insider trading activity for Bar Shalev Amos. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Director
Holding Value $0 0 shares
Last Trade
Nov 18, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$314 168 shares
$1.87
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Director
Holding Value $30.2k 15,000 shares
Last Trade
Sep 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.6k 15,000 shares
$1.64
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Director
Holding Value $124k 61,676 shares
Last Trade
Sep 29, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$102k 61,676 shares
$1.66
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Director
Holding Value $101k 50,000 shares
Last Trade
Sep 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$51.5k 50,000 shares
$1.03
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Director
Holding Value $80.4k 40,000 shares
Last Trade
Jan 20, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$142k 40,000 shares
$3.55
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Director
Holding Value $3.38k 1,680 shares
Last Trade
Dec 02, 2009 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$52.8k 680 shares
$77.70
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Director
Holding Value $2.01k 1,000 shares
Last Trade
Dec 02, 2009 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$77.7k 1,000 shares
$77.70
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
10% owner
Holding Value $12.4M 6,186,046 shares
Last Trade
Dec 31, 2006 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$2.01

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up